WORLD Longer interval between doses boosts CoronaVac efficacy, says Brazilian institute


Longer interval between doses boosts CoronaVac efficacy, says Brazilian institute


16:55, April 13, 2021

A healthcare worker shows the syringe to a woman after applying a dose of Sinovac's CoronaVac coronavirus disease (COVID-19) vaccine at Cacique de Ramos, one of the most traditional carnival blocks of Rio de Janeiro, Brazil on April 8, 2021. (Photo: Agencies)

SAO PAULO - A new study led by Brazil's biomedical Butantan Institute has shown that China's CoronaVac vaccine can be more effective at protecting against COVID-19 with a longer interval between the two doses.

The study was published on preprints database SSRN and submitted to the medical journal The Lancet on Sunday for peer review.

Data from a subgroup of 12,396 participants shows that the vaccine's efficacy rate grew to 62.3 percent when the doses were given at an interval of 21 days or longer.

"This study corroborates what we had already announced about three months ago and gives us even more confidence about the effective protection provided by the vaccine," Dimas Covas, director of the institute, told Brazil's TV network GloboNews.

The study also shows that CoronaVac is effective against P1, a more contagious variant that emerged in Amazonas in November.

Butantan Institute, a local producer of the CoronaVac vaccine from the Chinese laboratory Sinovac, has supplied doses for Brazil's mass vaccination campaign since Jan 17.

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue